lecture 4: study designs Flashcards

(40 cards)

1
Q

observe the outcomes without intervening to affect them

A

observational study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The researcher manipulates the exposure (usually a drug or treatment) to compare it to the standard of care

A

Experimental studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

types of observational studies

A

cohort
case control
cross-section

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Subjects are selected based their exposure status

A

Cohort studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

compares disease prevalence in the exposed and unexposed

A

Prospective cohort

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

begin with the exposure of interest and probe back for exposure information

A

Retrospective cohort

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

disadvantages of cohort studies

A

expensive
Inefficient for rare diseases
long follow up
Diagnostic trends

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Subjects are selected based on their disease status

A

Case-Control Studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cases and controls should be different only on their past exposure

A

Case-Control Studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Can demonstrate risk indicators and not risk factors due the retrospective nature of the study design

A

Case-Control Studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The exposure has to be assessed retrospectively and the proportions of cases and controls who are exposed are unknown at the beginning of the study

A

Case-Control Studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

must have had an equal chance of being exposed case-control studies

A

cases and controls

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Efficient for rare diseases

A

Case-coontrol studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Inefficient for rare diseases

A

cohort studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

allow for the evaluation of multiple exposures that may increase risk for a specific disease

A

case-control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cannot directly compute incidence of disease in exposed and non-exposed persons

A

case-control studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Not optimal for rare exposures

A

case-control studies

18
Q

selection of subjects based on neither exposure or disease status

A

Cross-sectional Studies

19
Q

Most basic study design

A

Cross-sectional Studies

20
Q

Subject selected without regards to exposure or disease status

A

Cross-sectional Studies

21
Q

point-in-time” or “snapshots” information

A

Cross-sectional Studies

22
Q

Does not need explained etiologic objectives

A

Cross-sectional Studies

23
Q

Sampling and analytic methods provide for statistically valid inference to populations

A

advantages of cross sectional studies

24
Q

Exposure and disease are assessed at the individual level

A

advantages of cross sectional studies

25
Temporality cannot be assessed
Cross-sectional Studies
26
Randomized clinical trial and Community intervention trials
Experimental studies
27
typical type of study used in clinical medicine
Randomized Clinical Trial (RCT)
28
Are sub-types of cohort studies in which exposure (i.e., treatment) is randomly assigned by the investigator
Randomized Clinical Trial (RCT)
29
The process by which each participant’s treatment is determined by some random mechanism
randomization of RCT's
30
minimizes confounding (known and unknown) results
randomized RCT's
31
create groups (experimental and control) that are not determined by any other factor other than by chance
using randomized RTC's
32
the investigator and/or the participant do not know what arm the participant is in
blinding in RCT's
33
the participant does not know but investigator does know treatment assignment
single blinded
34
where neither participant nor investigator know treatment assignment
double blinded
35
purpose of blinding
to remove bias or systematic error
36
drawing different conclusions depending on their knowledge of which study arm particular participant is in
Information bias
37
study recruiters can be eager to recruit “sick persons” into experimental arm
Selection bias
38
Considerations in experimental studies
Stopping rules Sample size Analysis and Interpretation
39
systematic complete summary of the literature
Systematic Review
40
combined analysis of data from different studies following strict guidelines
Meta-analysis